RifamycinS

Modify Date: 2025-08-25 13:39:37

RifamycinS Structure
RifamycinS structure
Common Name RifamycinS
CAS Number 13553-79-2 Molecular Weight 695.753
Density 1.3±0.1 g/cm3 Boiling Point 917.4±65.0 °C at 760 mmHg
Molecular Formula C37H45NO12 Melting Point 179-181ºC (dec.)
MSDS N/A Flash Point 508.6±34.3 °C

 Use of RifamycinS


Rifamycin S is a quinone and an antibiotic agnet against Gram-positive bacteria (including MRSA). Rifamycin S is the oxidized forms of a reversible oxidation-reduction system involving two electrons. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. Rifamycin S can be used for tuberculosis and leprosy[1][2][3].

 Names

Name Rifamycin S
Synonym More Synonyms

 RifamycinS Biological Activity

Description Rifamycin S is a quinone and an antibiotic agnet against Gram-positive bacteria (including MRSA). Rifamycin S is the oxidized forms of a reversible oxidation-reduction system involving two electrons. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. Rifamycin S can be used for tuberculosis and leprosy[1][2][3].
Related Catalog
Target

Gram-positive bacteria[3] Reactive oxygen species (ROS)[1]

In Vitro The inhibition of bacterial growth by Rifamycin SV is due to the production of active species of oxygen resulting from the oxidation-reduction cycle of Rifamycin SV in the cells. The aerobic oxidation of Rifamycin SV to Rifamycin S is induced by metal ions, such as Mn2+, Cu2+, and Co2+. The most effective metal ion is Mn2+[2].
In Vivo Rat liver sub-mitochondrial particles also generated hydroxyl radical in the presence of NADH and Rifamycin S. NADH dehydrogenase (complex I) as the major component involved in the reduction of Rifamycin S. Compared to NADPH, NADH is almost as effective (Rifamycin S) in catalyzing the interactions of these antibiotics with rat liver microsomes. Rifamycin S is shown to be readily reduced to Rifamycin SV, the corresponding hydroquinone by Fe(II). Rifamycin S forms a detectable Fe(II)-(Rifamycin S)3 complex. The Fe:ATP induced lipid peroxidation is completely inhibited by Rifamycin S. Rifamycin S can interact with rat liver microsomes to undergo redox-cycling, with the subsequent production of hydroxyl radicals when iron complexes are present[1].
References

[1]. Rao DN, et al. A comparative study of the redox-cycling of a quinone (rifamycin S) and a quinonimine (rifabutin) antibiotic by rat liver microsomes. Free Radic Biol Med. 1997;22(3):439-46.

[2]. Kono Y. Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. J Biochem. 1982 Jan;91(1):381-95.

[3]. Huang H, et al. Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica. Antonie Van Leeuwenhoek. 2009 Feb;95(2):143-8.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 917.4±65.0 °C at 760 mmHg
Melting Point 179-181ºC (dec.)
Molecular Formula C37H45NO12
Molecular Weight 695.753
Flash Point 508.6±34.3 °C
Exact Mass 695.294189
PSA 194.99000
LogP 2.87
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.605
InChIKey BTVYFIMKUHNOBZ-PZCBORFTSA-N
SMILES COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)C=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O
Storage condition 2-8°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KD1925000
CHEMICAL NAME :
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b) furan-1,6,9,11(2H)-te trone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22 -heptamethyl-, 21-acetate
CAS REGISTRY NUMBER :
13553-79-2
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C37-H45-N-O12
MOLECULAR WEIGHT :
695.83
WISWESSER LINE NOTATION :
T C6 B65-24- A D E 2BC G& AV DV GV LO NO F&VM OU B&U D&U MHT&&TJ IQ J1 M1 QO1 R1 SOV1 T1 UQ V

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- Volume(issue)/page/year: 16,412,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
258 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85ERAY "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978 Volume(issue)/page/year: 1,865,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
122 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85ERAY "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978 Volume(issue)/page/year: 1,865,1978

 Safety Information

RTECS KD1925000
HS Code 2941903000

 Synthetic Route

~92%

RifamycinS Structure

RifamycinS

CAS#:13553-79-2

Literature: Seong, Baik Lin; Han, Moon Hi Chemistry Letters, 1982 , p. 627 - 628

~%

RifamycinS Structure

RifamycinS

CAS#:13553-79-2

Literature: Journal of the Chemical Society, Chemical Communications, , p. 395 - 396

~%

RifamycinS Structure

RifamycinS

CAS#:13553-79-2

Literature: Journal of the Chemical Society, Chemical Communications, , p. 395 - 396

 Customs

HS Code 2941903000

 Articles26

More Articles
Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition.

Nat. Prod. Rep. 31(4) , 504-13, (2014)

Despite the longstanding importance of polyketide natural products in human medicine, nearly all commercial polyketide-based drugs are prepared through fermentation or semi-synthesis. The paucity of m...

Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.

Bioorg. Med. Chem. Lett. 21 , 6094-9, (2011)

A series of rifamycin S and rifampin analogues incorporating substituted 8-amino, 8-thio, and 1,8-pyrazole substituents has been synthesized. The compounds were made by activation of the C-8 phenol as...

Direct generation of acyclic polypropionate stereopolyads via double diastereo- and enantioselective iridium-catalyzed crotylation of 1,3-diols: beyond stepwise carbonyl addition in polyketide construction.

J. Am. Chem. Soc. 133(32) , 12795-800, (2011)

Under the conditions of transfer hydrogenation employing the cyclometalated iridium catalyst (R)-I derived from [Ir(cod)Cl](2), allyl acetate, 4-cyano-3-nitrobenzoic acid, and the chiral phosphine lig...

 RifamycinSBioassay

View more

Name: Antibacterial activity against Staphylococcus aureus 2999
Source: ChEMBL
Target: Staphylococcus aureus
External Id: CHEMBL998299
Name: Antibacterial activity against Escherichia coli 1074
Source: ChEMBL
Target: Escherichia coli
External Id: CHEMBL998304
Name: Antibacterial activity against Haemophilus influenzae
Source: ChEMBL
Target: Haemophilus influenzae
External Id: CHEMBL998302
Name: Antibacterial activity against Neisseria gonorrhoeae
Source: ChEMBL
Target: Neisseria gonorrhoeae
External Id: CHEMBL998303
Name: Antibacterial activity against Streptococcus pneumoniae
Source: ChEMBL
Target: Streptococcus pneumoniae
External Id: CHEMBL998300
Name: HIV Cellular Data
Source: NIAID
Target: N/A
External Id: HIV Cellular Data
Name: Antibacterial activity against Streptococcus faecalis 1362/3
Source: ChEMBL
Target: Enterococcus faecalis
External Id: CHEMBL998301
Name: Antimicrobial activity against Escherichia coli EC2880 mutant after 16 to 20 hrs
Source: ChEMBL
Target: Escherichia coli
External Id: CHEMBL1914230
Name: Antimicrobial activity against wild type Escherichia coli DH5[alpha] after 16 to 20 h...
Source: ChEMBL
Target: Escherichia coli
External Id: CHEMBL1914229
Name: Antibacterial activity against rifamycin-sensitive Staphylococcus aureus CB190 ATCC 2...
Source: ChEMBL
Target: Staphylococcus aureus
External Id: CHEMBL899818
Total 17, Current Page 1 of 2
1
2

 Synonyms

Rifamycin,1,4-dideoxy-1,4-dihydro-1,4-dioxo
UNII-PI53N820JV
rifomycin-S
rifamycin-S
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl acetate
NCI 144-130
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-trihydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,9,11-tetraoxo-1,2,6,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
EINECS 236-938-4
(12S,3E,5S,13E,15Z)-7t-acetoxy-15,9c,11t-trihydroxy-5r-methoxy-12,4,6t,8c,10c,12t,16-heptamethyl-2-oxa-18-aza-1(2,7)-naphtho[2,1-b]furana-cyclooctadecaphane-3,13,15-triene-11,6,9,17-tetraone
rifaximin S
O1,O4-didehydro-rifamycin
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triaconta-1(28),2,4,9 ,19,21,25-heptaen-13-yl acetate
1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin
RifamycinS
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.